Literature DB >> 1975805

Specialized localization of P-glycoprotein recognized by MRK 16 monoclonal antibody in endothelial cells of the brain and the spinal cord.

I Sugawara1, H Hamada, T Tsuruo, S Mori.   

Abstract

This communication describes the cellular and ultrastructural localization in the central nervous system of P-glycoprotein (P-GP) recognized by a murine monoclonal antibody, MRK 16. At the ultrastructural level P-GP was strictly confined to the luminal surface of the endothelial cells which comprise the capillary vessels of the brain and the spinal cord. No P-GP was found in the endothelial cells of other organs. Our findings may be useful as a means to define the blood-brain barrier, and they imply that the blood-brain barrier is anatomically characterized by the presence of intercellular tight junctions between continuous nonfenestrated endothelial cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1975805      PMCID: PMC5918087          DOI: 10.1111/j.1349-7006.1990.tb02636.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  10 in total

1.  Functional role for the 170- to 180-kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies.

Authors:  H Hamada; T Tsuruo
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

2.  Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites.

Authors:  C Cordon-Cardo; J P O'Brien; D Casals; L Rittman-Grauer; J L Biedler; M R Melamed; J R Bertino
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

3.  Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein.

Authors:  F Thiebaut; T Tsuruo; H Hamada; M M Gottesman; I Pastan; M C Willingham
Journal:  J Histochem Cytochem       Date:  1989-02       Impact factor: 2.479

Review 4.  The blood-brain barrier to proteins under normal and pathological conditions.

Authors:  M W Brightman; I Klatzo; Y Olsson; T S Reese
Journal:  J Neurol Sci       Date:  1970-03       Impact factor: 3.181

Review 5.  Multiple-drug resistance in human cancer.

Authors:  I Pastan; M Gottesman
Journal:  N Engl J Med       Date:  1987-05-28       Impact factor: 91.245

6.  Phosphorylation of the Mr 170,000 to 180,000 glycoprotein specific to multidrug-resistant tumor cells: effects of verapamil, trifluoperazine, and phorbol esters.

Authors:  H Hamada; K Hagiwara; T Nakajima; T Tsuruo
Journal:  Cancer Res       Date:  1987-06-01       Impact factor: 12.701

7.  Tissue distribution of P-glycoprotein encoded by a multidrug-resistant gene as revealed by a monoclonal antibody, MRK 16.

Authors:  I Sugawara; I Kataoka; Y Morishita; H Hamada; T Tsuruo; S Itoyama; S Mori
Journal:  Cancer Res       Date:  1988-04-01       Impact factor: 12.701

8.  Apparent stronger expression in the human adrenal cortex than in the human adrenal medulla of Mr 170,000-180,000 P-glycoprotein.

Authors:  I Sugawara; M Nakahama; H Hamada; T Tsuruo; S Mori
Journal:  Cancer Res       Date:  1988-08-15       Impact factor: 12.701

9.  Membrane vesicles from multidrug-resistant human cancer cells contain a specific 150- to 170-kDa protein detected by photoaffinity labeling.

Authors:  M M Cornwell; A R Safa; R L Felsted; M M Gottesman; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

10.  Cellular and tissue distribution of MRK20 murine monoclonal antibody-defined 85-kDa protein in adriamycin-resistant cancer cell lines.

Authors:  I Sugawara; E Ohkochi; H Hamada; T Tsuruo; S Mori
Journal:  Jpn J Cancer Res       Date:  1988-10
  10 in total
  20 in total

Review 1.  The impact of efflux transporters in the brain on the development of drugs for CNS disorders.

Authors:  Eve M Taylor
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 2.  Functional expression and localization of P-glycoprotein in the central nervous system: relevance to the pathogenesis and treatment of neurological disorders.

Authors:  Gloria Lee; Reina Bendayan
Journal:  Pharm Res       Date:  2004-08       Impact factor: 4.200

3.  Drug equilibration across the blood-brain barrier--pharmacokinetic considerations based on the microdialysis method.

Authors:  M Hammarlund-Udenaes; L K Paalzow; E C de Lange
Journal:  Pharm Res       Date:  1997-02       Impact factor: 4.200

4.  ABC transporter function and regulation at the blood-spinal cord barrier.

Authors:  Christopher R Campos; Christian Schröter; Xueqian Wang; David S Miller
Journal:  J Cereb Blood Flow Metab       Date:  2012-04-04       Impact factor: 6.200

5.  P-glycoprotein is strongly expressed in the luminal membranes of the endothelium of blood vessels in the brain.

Authors:  E Beaulieu; M Demeule; L Ghitescu; R Béliveau
Journal:  Biochem J       Date:  1997-09-01       Impact factor: 3.857

6.  Evidence for P-glycoprotein-modulated penetration of morphine-6-glucuronide into brain capillary endothelium.

Authors:  J Huwyler; J Drewe; C Klusemann; G Fricker
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

7.  BBB transport and P-glycoprotein functionality using MDR1A (-/-) and wild-type mice. Total brain versus microdialysis concentration profiles of rhodamine-123.

Authors:  E C de Lange; G de Bock; A H Schinkel; A G de Boer; D D Breimer
Journal:  Pharm Res       Date:  1998-11       Impact factor: 4.200

Review 8.  Human cell lines as models for multidrug resistance in solid tumours.

Authors:  M Clynes; M Heenan; K Hall
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

9.  Functional expression of the P-glycoprotein mdr in primary cultures of bovine cerebral capillary endothelial cells.

Authors:  D Lechardeur; D Scherman
Journal:  Cell Biol Toxicol       Date:  1995-10       Impact factor: 6.691

Review 10.  Elimination of substances from the brain parenchyma: efflux via perivascular pathways and via the blood-brain barrier.

Authors:  Stephen B Hladky; Margery A Barrand
Journal:  Fluids Barriers CNS       Date:  2018-10-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.